KTTA
Pasithea Therapeutics
Stock NASDAQ – Stock Market Prices, News & Analysis
Pasithea Therapeutics Corp est une entreprise biotechnologique axée sur la recherche et le développement de traitements pour les maladies neurologiques et psychiatriques.
Pasithea Therapeutics
KTTA
Pasithea Therapeutics Corp est une entreprise biotechnologique axée sur la recherche et le développement de traitements pour les maladies neurologiques et psychiatriques.
Price history of Pasithea Therapeutics
Price history of Pasithea Therapeutics
Performance & Momentum
Pasithea Therapeutics Raises $60M in Fundraising
Pasithea Therapeutics recently closed a $60 million public offering of common shares, extending its cash runway through H1 2028. This deal, backed by several major institutional investors, partly explains the strong rally in KTTA shares seen today.
Similar stocks to Pasithea Therapeutics
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
